Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Patient Square Capital Announces $3.9b Inaugural Fund (2023-02-01)
Patient Square Capital (“Patient Square”), a leading health care investment firm, announced today that it closed its inaugural fund with approximately $3.9 billion in total capital commitments. Patient Square Equity Partners (the “Fund”) surpassed its $3 billion ta...
Toulouse White Biotech (TWB) Partners with Premier Tech (2023-01-31)
TWB, expert in conducting R&D projects in industrial biotechnologies and designer of sustainable and innovative solutions, announces a strategic partnership with Premier Tech, a Canadian company with an international dimension. With 5,200 team members in 28 countri...
Sensorion & Eveon to Develop Gene Therapy Injection System (2023-01-31)
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, and EVEON, designer and manufacturer of custom medic...
Uniqure Licenses ALS Gene Therapy from Apic Bio (2023-01-31)
> License of APB-102 further strengthens uniQure’s pipeline of innovative gene therapies to treat neurological disorders and miRNA-based gene silencing programs > APB-102 and uniQure’s c9orf72-ALS program have the potential to address most inherited forms of ALS...
Endress+Hauser: Oliver Kläffling New CEO of Analytik Jena (2023-01-27)
A change is taking place at the top at Analytik Jena. Managing Director Ulrich Krauss has decided to assume other responsibilities outside of Analytik Jena. The Endress+Hauser Group is therefore handing over the management of the subsidiary specializing in laborato...
Evotec & Janssen to Develop Immune-based Therapies (2023-01-26)
STRATEGIC PARTNERSHIP LEVERAGES EVOTEC’S EXPERTISE & INTEGRATED PLATFORM FOR DISCOVERY AND DEVELOPMENT Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has entered into a strategic collabo...
Rewind Therapeutics Adds Funding, Sunstone LS New Investor (2023-01-25)
Claus Andersson, PhD, joins Rewind´s Board of Directors Rewind Therapeutics, a company developing first-in-class treatments for demyelination-associated diseases, today announced that it has raised additional funding, with Sunstone Life Science Ventures A/S j...
Crown Bioscience to Acquire Indivumed’s Service Business (2023-01-25)
Acquisition expands global service offering to include access and analysis of unique clinical biospecimens Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquir...
Sandoz Acquires Leading Antifungal Mycamine from Astellas (2023-01-24)
> Sandoz plans to acquire worldwide product rights for Mycamine®(micafungin sodium) from Astellas > Acquiring leading global echinocandin, one of three major antifungal classes, will significantly reinforce Sandoz hospital offering and leading anti-infectives po...
Alzinova Appoints Sebastian Hansson as BusDev Director (2023-01-24)
Alzinova AB (publ) (“Alzinova” or the “Company”) is pleased to announce that the Company has strengthened its management team by appointing Sebastian Hansson as the new Business Development Director. In this newly created role, Sebastian will be instrumental in dri...

» Show all News!

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]